Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine storm syndromes, and that these are a major driver of mortality.
The treatment of cytokine storms is one of the areas we are targeting with our magnetic blood filtration technology, which could be used to remove of IL-6, a major inflammatory cytokine which drives dysregulated immune responses. While we are not yet ready to trial this on humans, the current pandemic is extra motivation for us to work even harder on our technology in order to make it available to the world as soon as we can. The current pandemic is a stark reminder to us all of the importance of our work and its potential impact. In the meantime, we are trying to support the local community by offering access to our 3D printers and sending spare PPE gear to local hospitals. Our international team have also translated the ViralKindness self-isolating postcards, which we are spreading via our social media channels. It is now available in French, Italian, German, Russian, Gaeilge, Spanish, and Catalan! Help us spread #viralkindness: https://www.linkedin.com/posts/medisieve-limited_viralkindness-coronavirus-stayhomesavelives-activity-6648169217264758784-NnOl
MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study July 08, 2022
MediSieve at Industry Events In June 2022 June 29, 2022